- Home
- NUVB vs AMSF Comparison
NUVB vs AMSF Comparison
Compare NUVB & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- AMSF
- Stock Information
- Founded
- NUVB 2018
- AMSF 1985
- Country
- NUVB United States
- AMSF United States
- Employees
- NUVB N/A
- AMSF N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- NUVB Health Care
- AMSF Finance
- Exchange
- NUVB Nasdaq
- AMSF Nasdaq
- Market Cap
- NUVB 959.2M
- AMSF 987.4M
- IPO Year
- NUVB N/A
- AMSF 2005
- Fundamental
- Price
- NUVB $2.58
- AMSF $51.11
- Analyst Decision
- NUVB Strong Buy
- AMSF Buy
- Analyst Count
- NUVB 6
- AMSF 2
- Target Price
- NUVB $7.00
- AMSF $59.50
- AVG Volume (30 Days)
- NUVB 2.8M
- AMSF 91.2K
- Earning Date
- NUVB 02-27-2025
- AMSF 02-26-2025
- Dividend Yield
- NUVB N/A
- AMSF 2.89%
- EPS Growth
- NUVB N/A
- AMSF N/A
- EPS
- NUVB N/A
- AMSF 3.21
- Revenue
- NUVB $2,162,000.00
- AMSF $315,182,000.00
- Revenue This Year
- NUVB N/A
- AMSF N/A
- Revenue Next Year
- NUVB $369.72
- AMSF $0.88
- P/E Ratio
- NUVB N/A
- AMSF $15.95
- Revenue Growth
- NUVB N/A
- AMSF 2.81
- 52 Week Low
- NUVB $1.52
- AMSF $41.97
- 52 Week High
- NUVB $4.16
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- NUVB 45.02
- AMSF 43.95
- Support Level
- NUVB $2.47
- AMSF $50.66
- Resistance Level
- NUVB $2.77
- AMSF $52.29
- Average True Range (ATR)
- NUVB 0.23
- AMSF 0.95
- MACD
- NUVB -0.04
- AMSF 0.27
- Stochastic Oscillator
- NUVB 13.30
- AMSF 69.82
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.